Connection

Elizabeth Garrett-Mayer to Tumor Burden

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Tumor Burden.
Elizabeth Garrett-Mayer
Connection Strength
0.057
Tumor Burden
  1. K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate. Clin Cancer Res. 2010 Jan 01; 16(1):338-47.
    View in: PubMed
    Score: 0.020
  2. Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation. Chest. 2009 Jun; 135(6):1580-1587.
    View in: PubMed
    Score: 0.019
  3. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009 Jan; 58(1):49-59.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.